The Use of Methylphenidate in Cancer Patients: A Review.
CONCLUSION: This review potentially supports the use of methylphenidate for opioid-induced sedation, cognitive decline and fatigue in cancer patients. Further placebo-controlled trials would help in strengthening the evidence for this treatment.
PMID: 28322161 [PubMed - as supplied by publisher]
Source: Current Drug Targets - Category: Drugs & Pharmacology Authors: Andrew B, Ng CG, Jaafar NR Tags: Curr Drug Targets Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Concerta | Depression | Drugs & Pharmacology | Methylphenidate | Pain | Pain Management | Ritalin | Study